NCT06776497

Brief Summary

This study was conducted to examine the effect of a video played with VRG during arteriovenous fistula needle insertionon pain and anxiety of patients undergoing haemodialysis treatment. The sample of the study consisted of a total of 80 patients including 40 in the interventiongroup and 40 in control group who were treated in the haemodialysis ward. The data were collected using aPersonal Information Form prepared by the researcher upon review of the relevant literature to identify the patient's descriptive and medical characteristics, the Visual Analogue Scale (VAS) to assess the severity of pain, and the State-Trait Anxiety Inventory to determine the level of anxiety and VRH.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 15, 2025

Completed
Last Updated

January 15, 2025

Status Verified

March 1, 2024

Enrollment Period

6 months

First QC Date

December 10, 2024

Last Update Submit

January 14, 2025

Conditions

Keywords

AnxietyHemodialysisVirtual reality glassesPain

Outcome Measures

Primary Outcomes (2)

  • The Visual Analogue Scale (VAS)

    The Visual Analogue Scale (VAS) is a tool used to assess the severity of pain. The visual analog scale is a pain rating scale first used by Hayes and Patterson in 1921. It is used to quantify pain that cannot be measured numerically. Two extreme definitions of the pain parameter are written on the two ends of a 100-mm strip, and the patient is asked to indicate where his or her condition fits on this strip by drawing a line, dotting, or marking. It was also found that this scale was easy to understand and applicable for patients over five years of age and was a successful method for assessing the effectiveness of the pain relief method applied. It is a 100-mm (10-cm) ruler that can be used either horizontally or vertically, with no pain at one end and the worst pain at the other end."0 mm" indicates no pain, and "100 mm" indicates the worst pain. The individual indicates the severity of pain felt on this ruler. Based on these data, the horizontally prepared VAS was used to identify th

    one week

  • State-Trait Anxiety Inventory

    State-Trait Anxiety Inventory was developed by Spielberger et al., to assess state and trait anxiety levels and adapted into Turkish by Öner and Lecompte.The scale is based on the two-factor anxiety concept. The Kuder-Richardson reliability of the inventory was found to range from 83 to 87 for the trait anxiety subscale and 94 to 96 for the state anxiety subscale. The test-retest reliability rates of the inventory ranged from 71 to 86 for the trait anxiety subscale and from 26 to 68 for the State Anxiety subscale and were considered adequate.In this study, Cronbach's alpha reliability coefficient of the State-Trait Anxiety Inventory was found to be 0.73 for the State Anxiety Inventory and 0.75 for the Trait Anxiety Inventory. The State-Trait Anxiety Inventory consists of a total of 40 items. The first 20 items assess the state-related anxiety level, while the items from 21 to 40 assess the trait anxiety level of the individual.

    one week

Study Arms (2)

intervention

EXPERIMENTAL

The AVF catheter was inserted into the patients in the virtual reality group just before the clinic's standard haemodialysis procedure (5 minutes earlier), and the video continued to be played until the end of ten minutes after they were connected to the haemodialysis machine. Five minutes after the individual began watching the video, a routine AVF procedure was performed while the individual was still watching the video. During the haemodialysis, the patients in the VRGgroup were allowed to watch videos that they wanted to watch, such as walking in parks, nature and seaside hikes, underwater, museum tours, and feature films with VRGfor 10 minutes. After the time was up, the virtual reality application was terminated, and the VAS and the State-Trait Anxiety Inventory were filled out.

Device: VIRTUAL REALITY GLASSES (VRG)

control

NO INTERVENTION

The control group was subjected to AVF catheter insertion for the standard haemodialysis procedure of the clinic. According to this standard practice, the patients were not subjected to any procedure before AVF access. After they were connected to the haemodialysis machine, the VAS and the StateTrait Anxiety Inventory were completed.

Interventions

Individuals who met the inclusion criteria and signed the informed consent form were assigned to the study groups based on a list which was numbered and generated in the computer environment before the arteriovenous fistula (AVF) procedure. According to the results given by the computer programme, the individuals were assigned to the control group and the virtual realitiy group (VRG)group. While the control group included patients who underwent AVF procedure with the standard method, the virtual reality headset group included patients who underwent AVF procedure during the VRG application.

intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those aged 18 years and older,
  • Those who were not pregnant and had no plans to become pregnant,
  • Those who had been undergoing HD treatment in HD wards for at least three months and three sessions per week,
  • Those who continued dialysis treatment at the same institution,
  • Those for whom there were no changes in the treatment programme during the research period,
  • Those who had no pain in any part of the body that would affect the study outcome and scored zero on the Visual Analogue Scale for pain at the time of admission,
  • Those who had not taken analgesics in the last 24 hours,
  • Those who could understand and communicate in Turkish,
  • Those who volunteered to participate in the study and signed the written informed consent form were included in the study.

You may not qualify if:

  • Those who declined to participate in the study,
  • Those with a diagnosed neurological disease such as epilepsy, Alzheimer's disease, Parkinson's disease,and Multiple Sclerosis.
  • Those with visual and hearing impairments,
  • Those who took anxiolytic and/or sedative medications,
  • Those who were clinically unstable,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erciyes Üniversty

Kayseri, Talas, 38039, Turkey (Türkiye)

Location

Related Publications (1)

  • Guler S, Ozturk S, Sahan S, Topaloglu US. The Effect of Video Streaming With Virtual Reality Glasses During Arteriovenous Fistula Needle Insertion on Pain and Anxiety of Individuals Undergoing Hemodialysis Treatment. Hemodial Int. 2025 Jul 24. doi: 10.1111/hdi.70010. Online ahead of print.

MeSH Terms

Conditions

Anxiety DisordersPain

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking done
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This study was designed as a randomized, controlled experimental clinical trial to determine the effectiveness of a video played with virtual reality glasseson pain at the vascular access site and anxiety during an AVF catheter procedure in individuals who were undergoing haemodialysis treatment.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Student

Study Record Dates

First Submitted

December 10, 2024

First Posted

January 15, 2025

Study Start

March 1, 2024

Primary Completion

August 30, 2024

Study Completion

August 30, 2024

Last Updated

January 15, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

there is no plan

Locations